At exit, Atrium Innovations (Atrium), was a globally recognised leader in the development, manufacturing, and commercialisation of innovative, science-based health products in the vitamin, mineral and supplement (“VMS”) sector. Find out how we supported them in becoming one of the fastest growing companies in the industry globally.
Atrium Innovations
Together we achieved
- The transformation of Atrium into a focused, brand-driven VMS leader with a global presence
- International expansion, with two of Atrium’s core brands delivering 4x market growth
- Accelerated new product development and channel growth, particularly e-commerce
- 0 FDA observations under the Fund’s ownership
This was accomplished by
- Simplifying the business and focusing on core brands
- The streamlining and improvement of operations throughout the company, implementing regulatory excellence in all
- Bringing together a strengthened management team with world-class leadership experience
- International expansion into new and existing markets outside of North America, including the UK, China, Austria and Germany
The metrics
2014
Acquisition year
2017
Exit year
€754m
Transaction value
50+
Distribution countries
1,400+
Employees
7
Manufacturing sites
0
FDA observations under the fund’s ownership